HTG Molecular Diagnostics

📍 Tucson, United States🗓 Founded 1997👥 76 employees💰 Last funded Aug 2016
Biotechnology Research🌐 htgmolecular.com
Website LinkedIn
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas. Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1997
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in HTG Molecular Diagnostics?
HTG Molecular Diagnostics has 1 investors on record on gritt.io.
When did HTG Molecular Diagnostics last raise funding?
The most recent investment in HTG Molecular Diagnostics recorded on gritt.io was in August 2016.
When was HTG Molecular Diagnostics founded?
HTG Molecular Diagnostics was founded in 1997.
What industry is HTG Molecular Diagnostics in?
HTG Molecular Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HTG Molecular Diagnostics based?
HTG Molecular Diagnostics is headquartered in Tucson, United States.